FDA Clearance Tracker · P990053
OXIFIRST FETAL OXYGEN SATURATION MONITORING SYSTEM
Last checked: Nov 20, 2026Latest source record: May 12, 2000 (this decision)Source: openFDAMethods & limitations
Decided
May 12, 2000
Approval withdrawn
Time to decision
234 days
Received Sep 21, 1999. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P990053
- Device name
- OXIFIRST FETAL OXYGEN SATURATION MONITORING SYSTEM
- Applicant
- Covidien, LLC
- Applicant location
- Boulder, CO
- Received
- Sep 21, 1999
- Decided
- May 12, 2000
- Decision
- Approval withdrawn
- Supplements
- 11 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Oximeter, fetal pulse (MMA)
- Device class
- Class III
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE NELLCOR N-400 FETAL OXYGEN SATURATION MONITORING SYSTEM (OXIFIRST(TM) SYSTEM).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code MMA (Oximeter, fetal pulse).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Covidien, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261070 · Decided Sep 15, 2026 · 167 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
K253527 · Decided Jul 1, 2026 · 230 days after receipt
Device type: Stapler, Surgical (GAG) · Hospital Medicine & Nursing
K253984 · Decided Jun 4, 2026 · 174 days after receipt
Device type: Endoscopic Video Imaging System / Software Component For Real Time Video Augmentation (SFE) · GI, Urology & Nephrology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.